Clinical Trial Update: Clinical Efficacy of Amoxicillin Given Twice or Three Times a Day Among Children With Non-severe Pneumonia [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the clinical efficacy of amoxicillin given twice daily versus three times daily in children with non-severe community-acquired pneumo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia

Drugs mentioned

• AMOXICILLIN (AMOXICILLIN)

Snippet

Sponsor: Federal University of Bahia | Conditions: Community-acquired Pneumonia | Phase 4 | Status: COMPLETED